CN115612501A - Liquid crystal composition, liquid crystal medium and electro-optical display element - Google Patents

Liquid crystal composition, liquid crystal medium and electro-optical display element Download PDF

Info

Publication number
CN115612501A
CN115612501A CN202210935726.9A CN202210935726A CN115612501A CN 115612501 A CN115612501 A CN 115612501A CN 202210935726 A CN202210935726 A CN 202210935726A CN 115612501 A CN115612501 A CN 115612501A
Authority
CN
China
Prior art keywords
radical
liquid crystal
formula
compound
crystal composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210935726.9A
Other languages
Chinese (zh)
Inventor
刘晓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TCL Huaxing Photoelectric Technology Co Ltd
Original Assignee
TCL Huaxing Photoelectric Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TCL Huaxing Photoelectric Technology Co Ltd filed Critical TCL Huaxing Photoelectric Technology Co Ltd
Priority to CN202210935726.9A priority Critical patent/CN115612501A/en
Publication of CN115612501A publication Critical patent/CN115612501A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems

Abstract

The application provides a liquid crystal composition, a liquid crystal medium and an electro-optical display element, wherein the liquid crystal composition comprises at least one or more compounds with a formula I, and X and K are introduced into the structure of the formula I 1 、K 2 、A 1 、A 2 、R 1 And R 2 The groups enable the dipole moment of the compound molecules to face the same direction, the polarity of the compound is reduced, the viscosity of the compound is further reduced, the response speed is also improved, the response time is shortened, and the display effect and the performance of the electro-optic display element are improved.

Description

Liquid crystal composition, liquid crystal medium and electro-optical display element
Technical Field
The application relates to the technical field of display, in particular to a liquid crystal composition, a liquid crystal medium and an electro-optical display element.
Background
Liquid crystal compounds are widely used in displays of electronic devices including, but not limited to, watches, mobile phones, televisions, and computers. The contrast and the response time of the display are affected by the optical, electrical and mechanical properties of the liquid crystal compound, so that the contrast and the response time of the display are poor, and the display effect and the performance of the display are affected. For example: at a voltage of 0V, the liquid crystal molecules in a VA (vertical alignment mode) display are aligned in a direction perpendicular to the glass substrate, and incident light perpendicular to the glass substrate cannot pass through the liquid crystal molecules, thereby exhibiting a good dark state effect. The IPS and FFS displays have poor contrast and response speed.
However, the optical, electrical and mechanical properties of the liquid crystal compound depend on its molecular structure and the structure of the substituent groups. Therefore, in order to improve the display effect and performance of the display, it is necessary to develop a liquid crystal material with faster response and higher contrast.
Disclosure of Invention
The application provides a liquid crystal composition, a liquid crystal medium and an electro-optical display element, which are used for solving the technical problem that the display effect of a display is insufficient due to small polarity, high viscosity and low response speed of a liquid crystal material.
In a first aspect, the present application provides a liquid crystal composition comprising at least one or more compounds having formula I:
Figure BDA0003782956110000021
wherein A is 1 、A 2 Each independently a single bond, O or S;
x is a single bond, -O-, -S-, -CH 2 -、-CH 2 CH 2 -or-CF 2 -;
K 1 、K 2 Each independently is H or F;
R 1 、R 2 each independently is H, F, cl, br, I, CN, SCN, NCS, CF 3 Or SF 5 Or each independently is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy group can be substituted by H, CN or CF 3 Substituted, and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、-C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、 -CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、-CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH-or-C ≡ C-substitution, and/or C ≡ C-substitution 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 At least one H of the alkynyloxy groups can be substituted by F, cl, br or I.
Optionally, in some embodiments herein, X is-O-or-S-.
Optionally, in some embodiments of the present application, A 1 、A 2 Each independently is S or O.
Optionally, in some embodiments of the present application, K 1 、K 2 At least one of the two is F.
Optionally, in some embodiments herein, R 1 、R 2 Each independently is C 1-7 Alkyl radical, C 1-7 Alkoxy radical, C 2-7 Alkenyl radical, C 2-7 Alkenyloxy radical, C 2-7 Alkynyl or C 2-7 An alkynyloxy group.
Alternatively, in some embodiments herein, the compound having formula I has the following structural formula:
Figure BDA0003782956110000031
any one of, wherein,
R 7 is C 1-15 Alkyl radical, C 2-15 Alkenyl or C 2-15 Alkynyl, and R 7 In which there are one or two CH 2 The radicals being able to be substituted by-O-, -CO-; -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 O or-OCH 2 -substitution;
R 2 is H, F, cl, br, I, CN, SCN, NCS, CF 3 Or SF 5 Or is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy radical being able to be replaced by H, CN or CF 3 Substituted, and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radicalBase, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、 -C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、 -CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH-or-C ≡ C-substitution, and/or C ≡ C-substitution 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 At least one H of the alkynyloxy groups can be substituted by F, cl, br or I.
Optionally, in some embodiments herein, IB is selected from the following structural formulas:
Figure BDA0003782956110000032
Figure BDA0003782956110000041
Figure BDA0003782956110000042
any one of the above. And/or, said IE is selected from the following structural formulae:
Figure BDA0003782956110000043
Figure BDA0003782956110000051
Figure BDA0003782956110000052
any of the above. And/or, the IH is selected from the following structural formula:
Figure BDA0003782956110000053
Figure BDA0003782956110000054
any of the above. And/or, said IN is selected from the following structural formulas:
Figure BDA0003782956110000061
Figure BDA0003782956110000062
any of the above. Said IQ is selected from the following structural formulas:
Figure BDA0003782956110000063
Figure BDA0003782956110000071
Figure BDA0003782956110000072
any one of the above. And/or, the IT is selected from the following structural formulas:
Figure BDA0003782956110000073
Figure BDA0003782956110000081
Figure BDA0003782956110000082
any one of the above.
Optionally, in some embodiments herein, the liquid crystal composition further comprises at least one or more compounds having formula II and/or at least one or more compounds having formula III:
R 3 -R'-R 4 formula II.
Wherein R is 3 、R 4 Each independently is C 1-10 Alkyl radical, C 1-10 Alkoxy radical, C 2-10 Alkenyl radical, C 2-10 Alkenyloxy radical, C 2-10 Alkynyl or C 2-10 Alkynyloxy, and R 3 、R 4 Wherein at least one H atom can be substituted by F, cl, br or I;
r' is:
Figure BDA0003782956110000083
Figure BDA0003782956110000084
R 5 -R"-R 6 and (3) a formula III.
Wherein R is 5 、R 6 Each independently is C 1-10 Alkyl radical, C 1-10 Alkoxy radical, C 2-10 Alkenyl radical, C 2-10 Alkenyloxy radical, C 2-10 Alkynyl or C 2-10 Alkynyloxy, and R 5 、R 6 Wherein at least one H atom can be substituted by F, cl, br or I.
R' is:
Figure BDA0003782956110000091
Figure BDA0003782956110000092
optionally, in some embodiments of the present application, the mass percentage of the compound having formula I is 1% to 50%, the mass ratio of the compound having formula II is 1% to 90%, and the mass percentage of the compound having formula III is 1% to 90%.
Optionally, in some embodiments of the present application, the mass percentage of the compound having formula I is 1% to 25%, the mass ratio of the compound having formula II is 10% to 70%, and the mass percentage of the compound having formula III is 10% to 70%.
In a second aspect of the present application, there is provided a liquid crystal medium comprising the liquid crystal composition described above.
A third aspect of the present application is to provide an electro-optical display element comprising a liquid crystal layer made of the above liquid crystal medium.
The application provides a liquid crystal composition comprising a compound having formula I by introducing X, K into the structure of formula I 1 、K 2 、A 1 、A 2 、R 1 And R 2 And the like, so that the dipole moments of the molecules of the compound face to the same direction, the polarity of the compound is reduced, the viscosity of the compound is further reduced, the response speed is also improved, the response time is shortened, and the display effect and the performance of the electro-optic display element are improved.
Detailed Description
The technical solutions in the embodiments of the present application will be described clearly and completely below, and it should be understood that the described embodiments are only a part of the embodiments of the present application, and not all embodiments. All other embodiments obtained by a person skilled in the art based on the embodiments in the present application without making any creative efforts shall fall within the protection scope of the present application. Furthermore, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the present application, are given by way of illustration and explanation only, and are not intended to limit the present application.
The present application provides a liquid crystal composition, a liquid crystal medium, and an electro-optical display element, each of which is described in detail below. It should be noted that the following description of the embodiments is not intended to limit the preferred order of the embodiments in the present application. In the following embodiments, the description of each embodiment has its own emphasis, and reference may be made to the related description of other embodiments for parts that are not described in detail in a certain embodiment.
Embodiments of the present application provide a liquid crystal composition comprising at least one or more compounds having formula I:
Figure BDA0003782956110000101
wherein, A 1 、A 2 Each independently a single bond, O or S.
X is a single bond, -O-, -S-, -CH 2 -、-CH 2 CH 2 -or-CF 2 -. In one embodiment, X is represented by O, and a dibenzofuran structure is introduced into formula I, which is useful for increasing the polarity of the liquid crystal compound. In another embodiment, X is S, and a dibenzothiophene structure is introduced into the formula I, so that the solubility of the liquid crystal compound is improved.
K 1 、K 2 Each independently is H or F. In one embodiment, K 1 、K 2 At least one of the two is F; when K is 1 、K 2 When both are F, it is advantageous to improve the polarity of the liquid crystal compound. In a specific example, A 1 、A 2 Each independently is O. X is-O-. K is 1 、K 2 Are all F. As shown in the formula I, F and O face to the same side in the molecule, so that the dipole moments of the molecules face to the same direction, which is beneficial to improving the polarity of the liquid crystal compound, thereby being beneficial to reducing the viscosity of the liquid crystal compound and further improving the response speed of the liquid crystal compound.
R 1 、R 2 Each independently of the others being H, F, cl, br, I, CN, SCN, NCS (isothiocyanato), CF 3 Or SF 5 Or each independently is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy group can be substituted by H, CN or CF 3 Substituted, and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、-C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、 -CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、-CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH-, or-C ≡ C-substitution. And/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy groups in which one or more H can be replaced by F, cl, br or I, are preferred, wherein one or more H is replaced by F or Cl.
It should be noted that:
the above-mentioned "alkyl", "alkenyl" or "alkynyl" represents a straight-chain or branched aliphatic hydrocarbon group having 1 to 15 (i.e., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15) carbon atoms.
R in formula I 1 And R 2 Each independently represents an alkyl group, which may be linear or branched. Each of these groups is preferably straight-chain, having 1, 2, 3, 4, 5, 6 or 7 carbon atoms and is accordingly preferably methyl, ethyl, propyl, butyl, pentyl, hexyl or heptyl.
R in the formula I 1 And R 2 Each independently represents an alkenyl or alkynyl group having 2 to 15 carbon atoms, which may be linear or branched and have at least one carbon-carbon double bond or carbon-carbon triple bond. It is preferably a straight-chain alkenyl or alkynyl group having 2 to 7 carbon atoms. Concretely, it is vinyl, prop-1-enyl, prop-2-enyl, but-1-enyl, but-2-enyl, but-3-enyl, pent-1-enyl, pent-2-enyl, pent-3-enyl, pent-4-enyl, hex-1-enyl, hex-2-enyl, hex-3-enyl, hex-4-enyl, hex-5-enyl, hept-1-enyl, hept-2-enyl, hept-3-enyl, hept-4-enyl, hept-5-enyl, hept-6-enyl, ethynyl, prop-1-ynyl, prop-2-ynyl, but-1-ynyl, but-2-ynyl, but-3-ynyl, pent-1-ynyl, pent-2-ynylAlkynyl, pent-3-ynyl, pent-4-ynyl, hex-1-ynyl, hex-2-ynyl, hex-3-ynyl, hex-4-ynyl, hex-5-ynyl, hept-1-ynyl, hept-2-ynyl, hept-3-ynyl, hept-4-ynyl, hept-5-ynyl or hept-6-ynyl, and the alkenyl may be both E and Z isomers. Of alkenyl and alkynyl groups, preferred is prop-2-enyl, but-3-enyl, pent-2-enyl, pent-3-enyl, pent-4-enyl, prop-2-ynyl, but-3-ynyl, pent-2-ynyl, pent-3-ynyl or pent-4-ynyl.
Groups or substituents of the compounds of the formula I according to the above-described embodiments of the present application or in the form of optically active or stereoisomeric groups, substituents or compounds according to the compounds of the formula I themselves, which have an asymmetric or chiral center, are likewise included in the scope of protection of the present application. The compounds of the formula I mentioned above can exist in the form of isomers, such as pure enantiomers, diastereomers, E or Z isomers or as mixtures of a plurality of isomers in any desired ratio, for example as racemates, E/Z isomer mixtures.
In one embodiment, A is defined above as in formula I 1 In the case of O, R 1 And R 2 Preference is given to alkyl having 1 to 7 carbon atoms, particularly preferably 2 to 5 carbon atoms. In which A is 2 In the case of a single bond or O, R 2 Preferably represents alkyl, alkenyl or alkynyl, particularly preferably alkyl having 1 to 7 carbon atoms. At R 1 And R 2 The sum of the carbon atoms is preferably 4, 5, 6, 7, 8, 9, 10, particularly preferably 5, 6, 7, 8, 9.
In another embodiment, when A is in formula I above 1 In the case of a single bond, R 1 And R 2 Alkyl groups having 1 to 7 carbon atoms are preferred, with 2 to 5 carbon atoms being particularly preferred. In which A is 2 In the case of a single bond or O, R 2 Preferably represents alkyl, alkenyl or alkynyl, particularly preferably alkyl having 1 to 7 carbon atoms. At R 1 And R 2 The sum of the carbon atoms is preferably 4, 5, 6, 7, 8, 9, 10, particularly preferably 5, 6, 7, 8, 9.
In some embodiments, R 1 、R 2 Each independently represents C 2-7 Alkyl radical, C 3-6 Alkenyl radical, C 3-6 Alkynyl or CF 3 And R 1 And R 2 One or two CH of the group 2 The radicals being substituted by-O-, -CO-) -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 O or-OCH 2 -substitution.
In other embodiments of the present application, R 1 、R 2 Each independently is C 1-7 Alkyl radical, C 1-7 Alkoxy radical, C 2-7 Alkenyl radical, C 2-7 Alkenyloxy radical, C 2-7 Alkynyl or C 2-7 Alkynyloxy, and C 1-7 Alkyl radical, C 1-7 Alkoxy radical, C 2-7 Alkenyl, C 2-7 Alkenyloxy radical, C 2-7 Alkynyl or C 2-7 Having at least one or more CH groups in alkynyloxy groups 2 The radicals being able to be substituted by-O-, -C (O) O-; -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CH 2 O、-OCH 2 -, -CH = CH-or-C ≡ C-substitution; and C 1-7 Alkyl radical, C 1-7 Alkoxy radical, C 2-7 Alkenyl radical, C 2-7 Alkenyloxy radical, C 2-7 Alkynyl or C 2-7 One or more H of the alkynyloxy groups can be substituted by F. In one embodiment, R 1 、R 2 Each independently represents H or F, when R is 1 、R 2 When each is independently represented by F, it is advantageous to increase the polarity of the liquid crystal compound. In another embodiment, R 1 、R 2 Each independently is C 1-7 Alkyl radical, C 1-7 Alkoxy radical, C 2-7 Alkenyl radical, C 2-7 Alkenyloxy radical, C 2-7 Alkynyl or C 2-7 An alkynyloxy group.
In other embodiments of the present application, the compound having formula I has the following structural formula:
Figure BDA0003782956110000131
any one of (1), wherein R 7 Is C 1-15 Alkyl radical, C 2-15 Alkenyl or C 2-15 Alkynyl, and R 7 In which there are one or two CH 2 The radicals being able to be substituted by-O-, -CO- ] -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 O or-OCH 2 -substitution. R 2 Is H, F, cl, br, I, CN, SCN, NCS, CF 3 Or SF 5 Or is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy group can be substituted by H, CN or CF 3 Substituted, and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、-C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、-CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH-or-C ≡ C-substitution, and/or C ≡ C-substitution 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 At least one H of the alkynyloxy groups can be substituted by F, cl, br or I.
The structural formula of the IA-IX compound is introduced with a dibenzofuran structure or a dibenzothiophene structure, and the p-K 1 、K 2 、 A 1 And A 2 Optimizing and selecting the preferable group which is beneficial to improving the polarity of the liquid crystal compound to obtain the compound with higher dielectric, higher polarity and low viscosity. It is noted that the liquid crystal composition may comprise one or more of the above-mentioned IA-IX compounds.
In other embodiments of the present application, IB is selected from the following structural formulas:
Figure BDA0003782956110000141
Figure BDA0003782956110000142
any one of the above. In the structural formulas of IB1 to 16, an dibenzofuran structure is introduced, and A 1 And A 2 Is a single bond or O, K 1 And K 2 Each independently F, is beneficial to improving the polarity of the compound, thereby reducing the viscosity. The compound has the advantages of high dielectric property, high polarity, low viscosity and the like. IE is selected from the following structural formulas:
Figure BDA0003782956110000143
Figure BDA0003782956110000151
Figure BDA0003782956110000152
any one of them. In the structural formula of IE1-16, a dibenzofuran structure is introduced, and A 1 And A 2 Is a single bond or O, K 1 And K 2 Each independently F is beneficial to increase the polarity of the compound and thus reduce the viscosity. The compound has the advantages of high dielectric property, high polarity, low viscosity and the like.
IH is selected from the following structural formulas:
Figure BDA0003782956110000153
Figure BDA0003782956110000161
Figure BDA0003782956110000162
any one of them.In the structural formula of IH1-16, a dibenzofuran structure is introduced, and A 1 And A 2 Is a single bond or O, K 1 And K 2 Each independently F is beneficial to increase the polarity of the compound and thus reduce the viscosity. The compound has the advantages of high dielectric property, high polarity, low viscosity and the like.
IN is selected from the following structural formulas:
Figure BDA0003782956110000163
Figure BDA0003782956110000171
Figure BDA0003782956110000172
any one of them. IN the structural formula of IN1-16, a dibenzothiophene structure is introduced, and A 1 And A 2 Is a single bond or O, K 1 And K 2 Each independently F is beneficial to increase the polarity of the compound and thus reduce the viscosity. The compound has the advantages of high dielectric property, high polarity, low viscosity and the like.
IQ is selected from the following structural formulas:
Figure BDA0003782956110000173
Figure BDA0003782956110000181
any one of the above. In the structural formula of IQ1-16, a dibenzothiophene structure is introduced, and A 1 And A 2 Is a single bond or O, K 1 And K 2 Each independently F is beneficial to increase the polarity of the compound and thus reduce the viscosity. The compound has the advantages of high dielectric property, high polarity, low viscosity and the like.
IT is selected from the following structural formulae:
Figure BDA0003782956110000182
Figure BDA0003782956110000183
any one of the above. In the structural formula of IT1-16, a dibenzothiophene structure is introduced, and A 1 And A 2 Is a single bond or O, K 1 And K 2 Each independently F is beneficial to increase the polarity of the compound and thus reduce the viscosity. The compound has the advantages of high dielectric property, high polarity, low viscosity and the like.
In one embodiment, the compounds having formula I may be prepared by the following method:
s1, performing an addition reaction on a first compound to generate an addition product, wherein the first compound has a structural formula:
Figure BDA0003782956110000191
the structural formula of the addition product is:
Figure BDA0003782956110000192
s2, carrying out oxidation reaction on the addition product to obtain an oxidation product, wherein the structural formula of the oxidation product is as follows:
Figure BDA0003782956110000193
s3, carrying out cross coupling reaction on a second compound and the oxidation product to generate a coupling product, wherein the structural formula of the second compound is as follows:
Figure BDA0003782956110000194
the structural formula of the coupling product is:
Figure BDA0003782956110000195
s4, carrying out condensation reaction on the coupling product to generate a target product, wherein the structural formula of the target product is as follows:
Figure BDA0003782956110000196
the reaction process is as follows:
Figure BDA0003782956110000201
in the structural formulas of the first compound, the addition product, the oxidation product, the second compound, the coupling product and the target product, A 1 、A 2 Each independently a single bond, O or S.
K 1 、K 2 Each independently is H or F.
R 1 、R 2 Each independently of the others being H, F, cl, br, I, CN, SCN, NCS (isothiocyanato), CF 3 Or SF 5 Or each independently is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy group can be substituted by H, CN or CF 3 Substitution; and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、-C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、 -CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、-CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH-or-C ≡ C-substitution, and/or C ≡ C-substitution 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy has one or more H groups which can be substituted by F, cl, br or I.
In another embodiment, the compounds of formula I may be prepared by the following method:
s10, carrying out addition reaction on a first compound to generate an addition product, wherein the first compound has a structural formula as follows:
Figure BDA0003782956110000202
the structural formula of the addition product is as follows:
Figure BDA0003782956110000203
s20, carrying out oxidation reaction on the addition product to obtain an oxidation product, wherein the structural formula of the oxidation product is as follows:
Figure BDA0003782956110000211
s30, carrying out cross coupling reaction on a second compound and an oxidation product to generate a coupling product, wherein the structural formula of the second compound is as follows:
Figure BDA0003782956110000212
the structural formula of the coupling product is:
Figure BDA0003782956110000213
s40, carrying out condensation reaction on the coupling product in weak base to generate a first intermediate product, wherein the structural formula of the first intermediate product is as follows:
Figure BDA0003782956110000214
s50, carrying out rearrangement reaction on the first intermediate product to generate a second intermediate product, wherein the structural formula of the second intermediate product is as follows:
Figure BDA0003782956110000215
s60, carrying out condensation reaction on the second intermediate product to obtain a target product, wherein the structural formula of the target product is as follows:
Figure BDA0003782956110000221
the reaction process is as follows:
Figure BDA0003782956110000222
in the structural formulas of the first compound, the addition product, the oxidation product, the second compound, the coupling product, the first intermediate product, the second intermediate product and the target product, A 1 、A 2 Each independently a single bond, O or S.
K 1 、K 2 Each independently is H or F.
R 1 、R 2 Each independently of the other is H, F, cl, br, I, CN, SCN, NCS (isothiocyanato), CF 3 Or SF 5 Or each independently is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy radical being able to be replaced by H, CN or CF 3 Substitution; and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、-C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、 -CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、-CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH-or-C ≡ C-substitution, and/or C ≡ C-substitution 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy has one or more H groups which can be substituted by F, cl, br or I.
In other embodiments of the present application, a liquid crystal composition comprises: comprising at least one or more compounds of formula I, at least one or more compounds of formula II, and/or at least one or more compounds of formula III:
the structures of the compounds of formula I are as described above and are therefore not described herein in detail.
The compound having formula II is:
R 3 -R'-R 4 formula II.
Wherein R is 3 、R 4 Each independently is C 1-10 Alkyl radical, C 1-10 Alkoxy radical, C 2-10 Alkenyl radical, C 2-10 Alkenyloxy radical, C 2-10 Alkynyl or C 2-10 Alkynyloxy, and R 3 、R 4 Wherein at least one H atom can be substituted by F, cl, br or I.
R' is:
Figure BDA0003782956110000231
Figure BDA0003782956110000232
by adding the compound having formula II to the liquid crystal composition, it is advantageous to reduce the viscosity of the liquid crystal composition, increase the optical anisotropy (Δ n) of the liquid crystal composition, and improve the clearing point (Tni) of the composition.
The compound having formula III is:
R 5 -R″-R 6 formula III.
Wherein R is 5 、R 6 Each independently is C 1-10 Alkyl radical, C 1-10 Alkoxy radical, C 2-10 Alkenyl radical, C 2-10 Alkenyloxy radical, C 2-10 Alkynyl or C 2-10 Alkynyloxy, and R 5 、R 6 Wherein at least one H atom can be substituted by F, cl, br or I.
R' is:
Figure BDA0003782956110000233
Figure BDA0003782956110000241
by adding the compound with the formula III into the liquid crystal composition, the viscosity of the liquid crystal composition is favorably reduced, the dielectric of the liquid crystal composition is increased, and the clearing point of the liquid crystal composition is improved, so that the low-temperature performance of the liquid crystal composition is improved.
In some embodiments, the liquid crystal composition comprises the following components in percentage by mass: 1% -50% of a compound having formula I, 1% -90% of a compound having formula II, and 1% -90% of a compound having formula III. In another embodiment, the liquid crystal composition comprises the following components by mass percent: 1% -40% of a compound having formula I, 5% -70% of a compound having formula II, and 5% -70% of a compound having formula III. In another embodiment, the liquid crystal composition comprises the following components by mass percent: 1% -25% of a compound having formula I, 10% -70% of a compound having formula II, and 10% -70% of a compound having formula III. In particular, the liquid crystal composition may include one or more compounds having formula I, and when there are a plurality of compounds having formula I, the mixing ratio of the plurality of compounds having formula I is not limited in this example, and may be mixed in any ratio. The liquid crystal composition may also include one or more compounds having formula II, and when there are a plurality of compounds having formula II, the present embodiment does not limit the mixing ratio of the plurality of compounds having formula II, and the compounds may be mixed in any ratio. The liquid crystal composition may further include one or more compounds having formula III, and when there are a plurality of compounds having formula III, the mixing ratio of the plurality of compounds having formula III is not limited in this example, and may be mixed in any ratio.
In other embodiments of the present application, a liquid crystal medium is provided, which includes the above liquid crystal composition, and the liquid crystal composition is applied to the liquid crystal medium, and the liquid crystal composition has low viscosity, large polarity, fast response, and the like, has positive significance for developing a fast response display device, is suitable for blending of mixed liquid crystal, and is beneficial to improving the polarity of the liquid crystal medium, increasing the dielectric anisotropy of the liquid crystal medium, improving the clearing point (Tni, unit:. Degree. C) of the liquid crystal medium, and improving the low temperature performance of the liquid crystal medium. In some embodiments, the liquid crystal medium containing the liquid crystal composition provided in the embodiments of the present application is applied to a display in VA, ECB, PALC, FFS or IPS mode, and the display effect and performance of the display are improved.
In other embodiments of the present application, an electro-optic display element is provided that includes a liquid crystal layer made from the liquid crystal medium described above. The photoelectric performance of the electro-optical display element is improved, and the display effect and performance of the electro-optical display element are improved.
The technical effects of the present application will be further clarified below with reference to specific examples.
In each of the following examples, the liquid crystal composition was prepared by a thermal dissolution method comprising the steps of:
s100, weighing and preparing the components of the liquid crystal composition according to the mass percentage, wherein the weighing and adding sequence has no specific requirement, and the components are usually weighed and mixed at one time according to the sequence that the melting point of the liquid crystal compound is from low to high.
S200, heating and stirring at the temperature of 60-100 ℃ to fully dissolve and mix the components.
And S300, cooling to room temperature, and packaging to obtain a target sample.
Unless otherwise stated, the percentages in this example are mass percentages, and the temperature units are; tni represents the clearing point (unit:. Degree. C.) of the liquid crystal composition; Δ n represents the optical anisotropy at 25 ℃, n e Is the refractive index of the extraordinary ray; γ 1 represents the rotational viscosity at 25 ℃ (unit: mPas); Δ ε represents the dielectric anisotropy at 25 ℃,. Epsilon In the dielectric constant perpendicular to the long axis of the liquid crystal molecules, K11 is a splay elastic constant, and K33 is a bend elastic constant.
Example 1
Providing a liquid crystal composition, which comprises the following components in percentage by mass:
Figure BDA0003782956110000251
Figure BDA0003782956110000261
the performance parameters of the liquid crystal composition of this example are as follows in table 1:
Figure BDA0003782956110000262
TABLE 1
The liquid crystal composition is placed at the temperature of minus 20 ℃ for 480h without crystallization.
Example 2
The liquid crystal composition comprises the following components in percentage by mass:
Figure BDA0003782956110000271
Figure BDA0003782956110000281
the performance parameters of the liquid crystal composition of this example are as follows:
Figure BDA0003782956110000282
TABLE 2
The liquid crystal composition is placed at the temperature of minus 20 ℃ for 480h without crystallization.
Example 3
The liquid crystal composition comprises the following components in percentage by mass:
Figure BDA0003782956110000283
Figure BDA0003782956110000291
the performance parameters of the liquid crystal composition of this example are as follows in table 3:
Figure BDA0003782956110000292
Figure BDA0003782956110000301
TABLE 3
The liquid crystal composition is placed at the temperature of minus 20 ℃ for 480h without crystallization.
Example 4
The liquid crystal composition comprises the following components in percentage by mass:
Figure BDA0003782956110000302
Figure BDA0003782956110000311
the performance parameters of the liquid crystal composition of this example are as follows in Table 4:
Figure BDA0003782956110000312
TABLE 4
The liquid crystal composition is placed at the temperature of minus 20 ℃ for 480h without crystallization.
Example 5
Providing a liquid crystal composition, which comprises the following components in percentage by mass:
Figure BDA0003782956110000313
Figure BDA0003782956110000321
the performance parameters of the liquid crystal composition of this example are as follows:
Figure BDA0003782956110000322
TABLE 5
The liquid crystal composition is placed at-20 ℃ for 480h without crystallization.
Example 6
Providing a liquid crystal composition, which comprises the following components in percentage by mass:
Figure BDA0003782956110000331
Figure BDA0003782956110000341
the performance parameters of the liquid crystal composition of this example are as follows in Table 6:
Figure BDA0003782956110000342
TABLE 6
The liquid crystal composition is placed at the temperature of minus 20 ℃ for 480h without crystallization.
The performance parameters of the liquid crystal compositions of the above examples show that the liquid crystal compositions of the present application have a large polarity as a whole, i.e., Δ ∈, and play a favorable role in the response speed of liquid crystals. The response speed of displays such as IPS and FFS is determined by gamma 1/K 11 Judging, wherein the smaller the ratio is, the faster the response speed is; the response speed of VA display is based on gamma 1/K 33 It is judged that the smaller the ratio, the faster the response speed. As can be shown by the performance parameters of the above examples, the liquid crystal composition of the present application has the advantages of large polarity, low viscosity, fast response, etc.
The foregoing provides a detailed description of the present application, and the principles and embodiments of the present application are described herein using specific examples, which are merely used to help understand the method and the core ideas of the present application; meanwhile, for a person skilled in the art, according to the idea of the present application, there may be variations in specific embodiments and application ranges, and in summary, the content of the present specification should not be construed as a limitation to the present application.

Claims (12)

1. A liquid crystal composition comprising at least one or more compounds having formula I:
Figure FDA0003782956100000011
wherein A is 1 、A 2 Each independently a single bond, O or S;
x is a single bond, -O-, -S-, -CH 2 -、-CH 2 CH 2 -or-CF 2 -;
K 1 、K 2 Each independently is H or F;
R 1 、R 2 each independently is H, F, cl, br, I, CN, SCN, NCS, CF 3 Or SF 5 Or each independently is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy radical being able to be replaced by H, CN or CF 3 Substituted, and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、-C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、-CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 <xnotran> -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH- -C ≡ C- , / C </xnotran> 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 At least one H of the alkynyloxy groups can be substituted by F, cl, br or I.
2. The liquid crystal composition according to claim 1, wherein X is-O-or-S-.
3. Liquid crystal composition according to claim 1 or 2, characterized in that A is 1 、A 2 Each independently is S or O.
4. The liquid crystal composition according to claim 1 or 2, wherein K is 1 、K 2 At least one of the two is F.
5. The liquid crystal composition according to claim 1 or 2, wherein R is 1 、R 2 Each independently is C 1-7 Alkyl radical, C 1-7 Alkoxy radical, C 2-7 Alkenyl radical, C 2-7 Alkenyloxy radical, C 2-7 Alkynyl or C 2-7 An alkynyloxy group.
6. The liquid crystal composition of claim 1, wherein the compound having formula I has the following structural formula:
Figure FDA0003782956100000021
any one of, wherein,
R 7 is C 1-15 Alkyl radical, C 2-15 Alkenyl or C 2-15 Alkynyl, and R 7 In which there are one or two CH 2 The radicals being able to be substituted by-O-, -CO- ] -C (O) O-, -OC (O) -, -CF 2 O-、-OCF 2 -、-CH 2 O or-OCH 2 -substitution;
R 2 is H, F, cl, br, I, CN, SCN, NCS, CF 3 Or SF 5 Or is C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy, and C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 The terminal group of the alkynyloxy group can be substituted by H, CN or CF 3 Substituted, and/or C 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 Alkynyloxy having at least one CH 2 The radicals being able to be substituted by-O-, -S-, -SO 2 -、-CO-、-C(O)O-、-OC(O)-、-OC(O)O-、-CF 2 O-、-OCF 2 -、-CH 2 CH 2 -、-CF 2 CF 2 -、-CF 2 CH 2 -、-CH 2 CF 2 -、-CHF-CHF-、-CH 2 O、-OCH 2 -, -CF = CH-, -CH = CF-, -CF = CF-, -CH = CH-or-C ≡ C-substitution, and/or C ≡ C-substitution 1-15 Alkyl radical, C 1-15 Alkoxy radical, C 2-15 Alkenyl radical, C 2-15 Alkenyloxy radical, C 2-15 Alkynyl or C 2-15 At least one H of the alkynyloxy groups can be substituted by F, cl, br or I.
7. The liquid crystal composition of claim 6, wherein IB is selected from the following structures:
Figure FDA0003782956100000031
Figure FDA0003782956100000032
any one of (a) to (b); and/or
The IE is selected from the following structural formulas:
Figure FDA0003782956100000033
Figure FDA0003782956100000041
Figure FDA0003782956100000042
any one of the above; and/or
The IH is selected from the following structural formula:
Figure FDA0003782956100000043
Figure FDA0003782956100000051
Figure FDA0003782956100000052
any one of the above; and/or
The IN is selected from the following structural formulas:
Figure FDA0003782956100000053
Figure FDA0003782956100000054
any one of (1) and (b);
said IQ is selected from the following structural formulas:
Figure FDA0003782956100000061
Figure FDA0003782956100000062
any one of (a) to (b); and/or
The IT is selected from the following structural formulas:
Figure FDA0003782956100000063
Figure FDA0003782956100000071
Figure FDA0003782956100000072
any one of the above.
8. The liquid crystal composition of claim 1, further comprising at least one or more compounds having formula II and/or at least one or more compounds having formula III:
R 3 -R'-R 4 in the formula II, the compound is shown in the specification,
wherein R is 3 、R 4 Each independently is C 1-10 Alkyl radical, C 1-10 Alkoxy radical, C 2-10 Alkenyl radical, C 2-10 Alkenyloxy radical, C 2-10 Alkynyl or C 2-10 Alkynyloxy, and R 3 、R 4 Wherein at least one H atom can be substituted by F, cl, br or I;
r' is:
Figure FDA0003782956100000073
Figure FDA0003782956100000074
Figure FDA0003782956100000081
R 5 -R"-R 6
in the formula (III), the compound is shown in the formula,
wherein R is 5 、R 6 Each independently is C 1-10 Alkyl radical, C 1-10 Alkoxy radical, C 2-10 Alkenyl radical, C 2-10 Alkenyloxy radical, C 2-10 Alkynyl or C 2-10 Alkynyloxy, and R 5 、R 6 Wherein at least one H atom can be substituted by F, cl, br or I;
r' is:
Figure FDA0003782956100000082
Figure FDA0003782956100000083
9. the liquid crystal composition according to claim 8, wherein the mass percentage of the compound having the formula I is 1-50%, the mass ratio of the compound having the formula II is 1-90%, and the mass percentage of the compound having the formula III is 1-90%.
10. The liquid crystal composition according to claim 9, wherein the mass percentage of the compound having the formula I is 1-25%, the mass ratio of the compound having the formula II is 10-70%, and the mass percentage of the compound having the formula III is 10-70%.
11. A liquid crystal medium comprising the liquid crystal composition according to any one of claims 1 to 10.
12. An electro-optical display element comprising a liquid crystal layer made of a liquid crystal medium according to claim 11.
CN202210935726.9A 2022-08-04 2022-08-04 Liquid crystal composition, liquid crystal medium and electro-optical display element Pending CN115612501A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210935726.9A CN115612501A (en) 2022-08-04 2022-08-04 Liquid crystal composition, liquid crystal medium and electro-optical display element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210935726.9A CN115612501A (en) 2022-08-04 2022-08-04 Liquid crystal composition, liquid crystal medium and electro-optical display element

Publications (1)

Publication Number Publication Date
CN115612501A true CN115612501A (en) 2023-01-17

Family

ID=84856480

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210935726.9A Pending CN115612501A (en) 2022-08-04 2022-08-04 Liquid crystal composition, liquid crystal medium and electro-optical display element

Country Status (1)

Country Link
CN (1) CN115612501A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1942461A (en) * 2004-04-14 2007-04-04 默克专利股份有限公司 Dibenzofuran-, dibenzothiophene- and fluorene derivatives
US20150299161A1 (en) * 2014-04-22 2015-10-22 Merck Patent Gmbh 4,6-difluorodibenzothiophene derivatives
CN113508168A (en) * 2018-12-19 2021-10-15 默克专利股份有限公司 Compound, liquid crystal medium and liquid crystal display comprising same
CN113698942A (en) * 2020-05-22 2021-11-26 江苏和成显示科技有限公司 Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition and display device thereof
CN113845920A (en) * 2020-06-28 2021-12-28 江苏和成显示科技有限公司 Liquid crystal composition containing dibenzo derivative and liquid crystal display device
CN113845922A (en) * 2020-06-28 2021-12-28 江苏和成显示科技有限公司 Liquid crystal composition containing dibenzo derivative and liquid crystal display device
CN113845921A (en) * 2020-06-28 2021-12-28 江苏和成显示科技有限公司 Liquid crystal composition containing dibenzo derivative and liquid crystal display device thereof
WO2022084168A1 (en) * 2020-10-19 2022-04-28 Merck Patent Gmbh 4,6-difluorodibenzothiophene derivatives and liquid-crystal medium containing these

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1942461A (en) * 2004-04-14 2007-04-04 默克专利股份有限公司 Dibenzofuran-, dibenzothiophene- and fluorene derivatives
US20150299161A1 (en) * 2014-04-22 2015-10-22 Merck Patent Gmbh 4,6-difluorodibenzothiophene derivatives
CN113508168A (en) * 2018-12-19 2021-10-15 默克专利股份有限公司 Compound, liquid crystal medium and liquid crystal display comprising same
CN113698942A (en) * 2020-05-22 2021-11-26 江苏和成显示科技有限公司 Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition and display device thereof
CN113845920A (en) * 2020-06-28 2021-12-28 江苏和成显示科技有限公司 Liquid crystal composition containing dibenzo derivative and liquid crystal display device
CN113845922A (en) * 2020-06-28 2021-12-28 江苏和成显示科技有限公司 Liquid crystal composition containing dibenzo derivative and liquid crystal display device
CN113845921A (en) * 2020-06-28 2021-12-28 江苏和成显示科技有限公司 Liquid crystal composition containing dibenzo derivative and liquid crystal display device thereof
WO2022084168A1 (en) * 2020-10-19 2022-04-28 Merck Patent Gmbh 4,6-difluorodibenzothiophene derivatives and liquid-crystal medium containing these

Similar Documents

Publication Publication Date Title
CN113563899B (en) Positive polarity liquid crystal composition with high penetration rate and application thereof
CN113773857A (en) Liquid crystal composition with negative dielectric constant and application thereof
CN111826170A (en) PSA type liquid crystal composition and display device thereof
CN107267157B (en) Negative dielectric anisotropy liquid crystal composition and application thereof
JP2005281559A (en) Nematic liquid crystal composition and liquid display element using the same
JP4655479B2 (en) Nematic liquid crystal composition and liquid crystal display device using the same
CN114479879A (en) Liquid crystal composition with negative dielectric constant
JP2020079215A (en) Liquid crystal compound
CN115612501A (en) Liquid crystal composition, liquid crystal medium and electro-optical display element
CN110396412B (en) Liquid crystal composition and application thereof
EP1438371A1 (en) Nematic liquid crystal compound, and liquid crystal composition having high speed and high temperature comprising the same
CN108085020B (en) Negative dielectric anisotropy liquid crystal composition and application thereof
KR940001901B1 (en) Supertwisted nematic liquid crystal display device
CN114196423A (en) Liquid crystal composition containing positive and negative liquid crystal compounds and application thereof
JPH08239665A (en) Liquid crystal composition and liquid crystal display device
CN115746873A (en) Liquid crystal composition and liquid crystal display panel
CN117511560A (en) Liquid crystal composition and display panel
CN115895679A (en) Liquid crystal composition and display panel
CN112175631A (en) Liquid crystal composition and application thereof
CN115975651A (en) Liquid crystal composition and display panel
CN117511561A (en) Liquid crystal composition and display panel
CN108659859B (en) Liquid crystal composition having positive dielectric anisotropy and display device thereof
CN115746870A (en) Liquid crystal composition and liquid crystal display panel
CN117511566A (en) Liquid crystal composition and liquid crystal display panel
CN117487567A (en) Liquid crystal composition and liquid crystal display panel

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination